Creative Bioarray offers innovative Drug Discovery and Screening Services utilizing advanced organ-on-a-chip and organoid technologies. Our solutions provide a more accurate representation of human biology, allowing researchers to elucidate drug responses effectively, reduce reliance on animal models, and enhance the drug development process.
- Introduction
- Service Details
- Features
- FAQs
Innovative Solutions for Drug Discovery
In drug discovery, the challenge lies in accurately predicting how new drugs will perform in the human body. Traditional rodent models often fail to replicate human responses accurately, leading to high failure rates during clinical trials. Creative Bioarray's organ-on-a-chip and organoid platforms emulate human organ systems, enabling researchers to conduct high-throughput screening of compounds in a controlled, physiologically relevant environment.
Our technologies integrate multiple organ types to study drug interactions better, optimize lead candidates, and assess potential toxicities before progressing to clinical trials. By leveraging these advanced models, researchers can speed up the drug development process and improve the likelihood of success.
Fig. 1.
organ-on-a-chip has been utilized to model almost all human organs for drug testing, disease modeling,
personalized medicine, etc. (Deng S, Li C, et al., 2023).
Drug Discovery and Screening Services
Our Drug Discovery and Screening Services are designed to support pharmaceutical and biotechnology companies at various stages of drug development:
1. High-Throughput Drug Screening
- Utilization of microfluidic organ-on-a-chip systems to evaluate drug efficacy and toxicity across multiple organ types.
- Facilitates the assessment of pharmacokinetics and pharmacodynamics in a human-relevant context.
- Allows for real-time monitoring of cellular responses, providing immediate feedback on compound performance.
2. Mechanistic Studies
- In-depth analysis of drug mechanism of action through the interaction of compounds with organ-specific cells.
- Integration of biomarker panels for the evaluation of drug response and toxicity.
- Use of advanced imaging techniques to monitor live cell dynamics and assess drug effects over time.
3. Custom Assay Development
- Development of customized assays tailored to specific drug discovery goals, including disease modeling and compound screening.
- Using patient-derived cells to create relevant biological models for personalized medicine applications.
- Collaboration with clients to create assays that meet unique research objectives and regulatory requirements.
Technical Platform and Analysis
Our platform employs state-of-the-art technologies to yield reproducible, high-quality results:
Instrumentation:
- Advanced microfluidic devices
- Automated screening systems
- Live-cell imaging technology
Key Reagents:
- Customized cell culture media
- Standardized ECM components
- Validated biomarker panels for diverse drug assays.
Analysis Techniques:
- Functional endpoint assays
- Biomarker quantification through ELISA, qPCR
- High-Content analysis for detailed cell profiling.
Why Choose Creative Bioarray for Your Drug Discovery Journey?
- Our integrated organ models authentically reflect human physiology, helping you achieve accurate drug response assessments.
- We employ established methodologies and validated models, ensuring the reproducibility of your research findings.
- Our collaborative approach allows us to tailor services that meet your unique research needs, with flexible assay development options.
- Timely delivery of results is our mantra, backed by a streamlined process that keeps you updated at every step.
Need Support? Contact Us Today.
Our experts are ready to assist you in selecting the appropriate organ modules and assays that best suit your research requirements. At Creative Bioarray, we collaborate with you to optimize your drug discovery projects with state-of-the-art organ-chip technology.
FAQs
What types of drugs can be tested?
We can evaluate small molecules, biologics, and other therapeutic modalities through our organ-on-a-chip systems.
How do you ensure model relevance?
Our models are designed to mimic human organ physiology, utilizing primary cells or patient-derived cells to enhance translational relevance.
What is the typical turnaround time for results?
Depending on the complexity, results are generally delivered within 6–10 weeks following consultation.
Can I conduct multiple assays simultaneously?
Yes, our platforms are designed for flexibility, allowing for the simultaneous testing of multiple compounds across different conditions.
Transform Your Drug Discovery Process Today
Our team at Creative Bioarray is here to support your drug development initiatives with our premier Drug Discovery and Screening Services. Reach out today for a consultation, and let us assist you in accelerating your research efforts.
Online Inquiry